The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer: A systematic review

M. Timmermans*, O. van der Hel, G. S. Sonke, K. K. Van de Vijver, M. A. van der Aa, R. F. Kruitwagen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)445-451
Number of pages7
JournalGynecologic Oncology
Volume153
Issue number2
DOIs
Publication statusPublished - May 2019

Keywords

  • Neoadjuvant chemotherapy
  • Interval cytoreductive surgery
  • Outcome of surgery
  • Overall survival
  • ADVANCED-STAGE OVARIAN
  • PRIMARY CYTOREDUCTIVE SURGERY
  • INTERVAL DEBULKING SURGERY
  • GYNECOLOGIC ONCOLOGISTS
  • SURGICAL CYTOREDUCTION
  • AGGRESSIVE SURGERY
  • PERITONEAL CANCER
  • IV OVARIAN
  • SURVIVAL
  • CARCINOMA

Cite this